Literature DB >> 11843892

Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders.

B J Bain1, D Barnett, D Linch, E Matutes, J T Reilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11843892     DOI： 10.1046/j.1365-2257.2002.00135.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN： 0141-9854


× No keyword cloud information.
  7 in total

1.  Comparison of Immunohistochemistry, Cytochemistry, and Flow Cytometry in AML for Myeloperoxidase Detection.

Authors:  Ankur Ahuja; Seema Tyagi; Tulika Seth; Hara Prasad Pati; Gps Gahlot; Preeti Tripathi; Venkatesan Somasundaram; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2017-07-28       Impact factor: 0.900

2.  Gravin gene expression in acute myeloid leukemia.

Authors:  Mohamed R Mostafa; Raida S Yahia; Hanaa M Abd El Messih; Eman El-Sisy; Doaa M El Ghannam
Journal:  Med Oncol       Date:  2013-03-31       Impact factor: 3.064

3.  CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.

Authors:  Carlos Cuesta-Mateos; Patricia Fuentes; Alexandra Schrader; Raquel Juárez-Sánchez; Javier Loscertales; Tamara Mateu-Albero; Lorena Vega-Piris; Marina Espartero-Santos; Ana Marcos-Jimenez; Blanca Andrea Sánchez-López; Yaiza Pérez-García; Dennis Jungherz; Sebastian Oberbeck; Linus Wahnschaffe; Anna Kreutzman; Emma I Andersson; Satu Mustjoki; Edgar Faber; Ana Urzainqui; Manuel Fresno; Kostantino Stamatakis; Arantzazu Alfranca; Fernando Terrón; Marco Herling; María Luisa Toribio; Cecilia Muñoz-Calleja
Journal:  Biomark Res       Date:  2020-10-24

4.  Flowcytometric comparative analysis in acute leukemias between Indian and proposed minimal screening panel.

Authors:  Srishti Gupta; Tathagata Chatterjee; Sanjeevan Sharma; Ajay Sharma; Prosenjit Ganguly; Jasjit Singh; Satyaranjan Das
Journal:  Med J Armed Forces India       Date:  2016-03-29

5.  Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.

Authors:  Enrica Morra; Giovanni Barosi; Alberto Bosi; Felicetto Ferrara; Franco Locatelli; Monia Marchetti; Giovanni Martinelli; Cristina Mecucci; Marco Vignetti; Sante Tura
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

6.  Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia.

Authors:  T W Farren; J Giustiniani; M Fanous; F Liu; M G Macey; F Wright; A Prentice; A Nathwani; S G Agrawal
Journal:  Blood Cancer J       Date:  2015-01-23       Impact factor: 11.037

Review 7.  Role of Biomarkers in FLT3 AML.

Authors:  Jiao Wei; Ai-Min Hui
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.